{"id":"https://openalex.org/W7163216005","doi":"https://doi.org/10.1016/s1569-1993(26)00164-5","title":"Persistent decline in FEV1 in adults with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor","display_name":"Persistent decline in FEV1 in adults with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor","publication_year":2026,"publication_date":"2026-06-01","ids":{"openalex":"https://openalex.org/W7163216005","doi":"https://doi.org/10.1016/s1569-1993(26)00164-5"},"language":"en","primary_location":{"id":"doi:10.1016/s1569-1993(26)00164-5","doi":"https://doi.org/10.1016/s1569-1993(26)00164-5","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s1569-1993(26)00164-5","pdf_url":null,"source":{"id":"https://openalex.org/S147774598","display_name":"Journal of Cystic Fibrosis","issn_l":"1569-1993","issn":["1569-1993","1873-5010"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cystic Fibrosis","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087522944","display_name":"Pierre\u2010R\u00e9gis Burgel","orcid":"https://orcid.org/0000-0003-0903-9828","observed_orcids":["https://orcid.org/0000-0003-0903-9828"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P.-R. Burgel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5137672151","display_name":"A. Lafourcade","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Lafourcade","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037920967","display_name":"Antoine Bessou","orcid":"https://orcid.org/0009-0000-8770-426X","observed_orcids":["https://orcid.org/0009-0000-8770-426X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Bessou","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050010383","display_name":"Jennifer Da Silva","orcid":"https://orcid.org/0000-0001-6897-3616","observed_orcids":["https://orcid.org/0000-0001-6897-3616"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Da Silva","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5070019992","display_name":"Cl\u00e9mence Martin","orcid":"https://orcid.org/0000-0003-4385-5888","observed_orcids":["https://orcid.org/0000-0003-4385-5888"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. Martin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4370,"currency":"USD","value_usd":4370},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"25","issue":null,"first_page":"S10","last_page":"S10"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10665","display_name":"Cystic Fibrosis Research Advances","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10665","display_name":"Cystic Fibrosis Research Advances","score":0.9976000189781189,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11651","display_name":"Inhalation and Respiratory Drug Delivery","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/elexacaftor-tezacaftor-ivacaftor","display_name":"elexacaftor/tezacaftor/ivacaftor","score":0.9919999837875366},{"id":"https://openalex.org/keywords/cftr-modulator-therapy","display_name":"CFTR modulator therapy","score":0.925000011920929},{"id":"https://openalex.org/keywords/fev1-decline","display_name":"FEV1 decline","score":0.9580000042915344},{"id":"https://openalex.org/keywords/lung-function-decline","display_name":"lung function decline","score":0.8289999961853027},{"id":"https://openalex.org/keywords/adult-cystic-fibrosis","display_name":"adults with cystic fibrosis","score":0.6970000267028809}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.973800003528595},{"id":"https://openalex.org/C2776938444","wikidata":"https://www.wikidata.org/wiki/Q178194","display_name":"Cystic fibrosis","level":2,"score":0.9556000232696533},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5126000046730042},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.46059998869895935},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.31679999828338623},{"id":"https://openalex.org/C2780520431","wikidata":"https://www.wikidata.org/wiki/Q5201210","display_name":"Cystic fibrosis-related diabetes","level":5,"score":0.2694999873638153},{"id":"https://openalex.org/C2776737053","wikidata":"https://www.wikidata.org/wiki/Q7130407","display_name":"Pancreatic disease","level":3,"score":0.2685000002384186},{"id":"https://openalex.org/C2776178081","wikidata":"https://www.wikidata.org/wiki/Q3286546","display_name":"Respiratory disease","level":3,"score":0.25850000977516174},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.24079999327659607},{"id":"https://openalex.org/C205545832","wikidata":"https://www.wikidata.org/wiki/Q17156455","display_name":"Young adult","level":2,"score":0.21889999508857727}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/s1569-1993(26)00164-5","doi":"https://doi.org/10.1016/s1569-1993(26)00164-5","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s1569-1993(26)00164-5","pdf_url":null,"source":{"id":"https://openalex.org/S147774598","display_name":"Journal of Cystic Fibrosis","issn_l":"1569-1993","issn":["1569-1993","1873-5010"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cystic Fibrosis","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7163139491","https://openalex.org/W4281651180","https://openalex.org/W4281618394","https://openalex.org/W4387746212","https://openalex.org/W7163185160","https://openalex.org/W4414698814","https://openalex.org/W4281623505","https://openalex.org/W3207666554","https://openalex.org/W7163210761","https://openalex.org/W7163157659"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2026-06-03T00:00:00"}